-
3740 E Southern Ave, Ste 210
Mesa, AZ 85206 -
Monday–Friday, 9:00 AM – 6:00 PM MST
by appointment only -
Saturday
By Appointment -
Sunday
Closed
It can be hard to spot a change in depression, especially after months or years of symptoms. One day may feel better, while the next feels just as hard as before. If you use Spravato, you may wonder how your care team can tell if it works.
Spravato treatment progress involves more than a quick check of your mood. Your care team looks at symptoms over time, daily tasks, and side effects. For adults in Mesa, Arizona, knowing what these checks mean can help at follow-up visits. Here is what care teams look for and how to share small changes you might miss.
Depression does not always get better in a straight line. You might have a better morning followed by a difficult evening. A hard week may disrupt sleep or make it tough to start tasks, even as some signs ease. One day alone may not show the full picture.
According to the National Institute of Mental Health, depression affects how you feel, think, sleep, eat, and handle daily tasks. That is why check-ins cover more than feeling sad, including your energy, focus, and time with others.
Your care team also looks at where you began, since someone who could barely leave bed may notice progress by preparing breakfast. Another person may still work every day but begin enjoying activities again. Neither tells the whole story by itself.
A useful question is not just “Did I feel better today?” but “What has changed since treatment began?” Notes from a few weeks can help you answer it. A longer view helps you judge Spravato treatment progress with more care.
A baseline shows how you feel before care begins. Without it, you may forget what has changed. Your care team may ask which symptoms are worst and how often they occur.
The first check may cover:
Mood: sadness, irritability, emotional numbness, or hopelessness.
Thinking: focus, memory, indecision, or harsh self-criticism.
Body changes: sleep, hunger, low energy, or feeling slowed down.
Daily life: work, chores, time with others, and self-care.
Safety: thoughts of self-harm or sudden changes in mental health.
Past care matters too, so your care team needs to know what drugs or other care you tried, for how long, and how you felt. The Spravato service overview explains why a mental health review takes place before care starts.
A baseline is not a test you pass or fail; it gives you a point to look back on. Sharing hard days helps your care team judge Spravato treatment progress more fairly.
Your care team asks if symptoms feel less strong or happen less often, and whether those changes last between visits. Feeling different right after a dose is not the same as lasting relief.
According to the official Spravato prescribing information on DailyMed, the care team should review whether treatment has helped after the first four weeks for treatment-resistant depression. This check helps guide the next step.
Response means symptoms have eased by a clear amount from where they began. Remission means few or no symptoms remain. Neither term means depression can never return.
Your clinician may consider whether:
Symptoms are less severe or happen less often.
Improvement persists outside treatment sessions.
You can handle activities that previously felt unmanageable.
Side effects or new concerns affect the overall benefit.
Spravato treatment progress can be easier to judge after several check-ins. People respond in different ways, and some do not get enough relief.
A rating scale asks the same set of questions at each check-in. Repeating the same check can show trends that you might forget. Your care team reads that score alongside your story and how you feel now.
One tool used in Spravato research is the Montgomery-Åsberg Depression Rating Scale (MADRS). It has ten items that a care team uses to rate how severe depression is. Higher scores reflect more severe symptoms. The drug label explains how studies used changes in MADRS scores to track treatment effects.
In day-to-day care, your team may use another tested survey or a set of questions. Each practice may use a different tool, and a score can help you talk about changes without telling your whole story.
A lower depression score may show progress, even if work and sleep are still hard. That score matters, but so do the problems that remain. The reverse can happen too: you may be managing more of your day even though your total score has changed only a little.
Rating scales help guide care; they do not make the choice on their own. Share what feels new, what has not changed, and what feels harder. These details help explain Spravato treatment progress.
A better mood is not always the first sign of change, since some changes are quiet and show up in routine tasks. You might answer messages sooner, cook a meal, or feel less drained after a conversation. These details can help make Spravato treatment progress more concrete.
Consider keeping track of the areas that matter to you:
Sleep: falling asleep, waking during the night, and feeling rested.
Energy: starting tasks without as much effort or exhaustion.
Interest: wanting to see people or return to familiar hobbies.
Concentration: following a conversation, reading, or making decisions.
Function: getting through work, errands, or household routines.
Not every part of life has to improve at once, and one hard day does not erase past gains. Yet signs that do not improve still need care, even when one part of life feels better.
The related guide to what patients can expect during Spravato treatment covers the session experience and treatment schedule. Here, the focus is how clinicians assess changes in depression symptoms between appointments.
At check-ins, care teams ask about symptoms, past scores, daily life, and whether side effects are hard to bear. They may also review other drugs, health needs, and big life changes.
The next step may be to keep, change, or rethink the care plan. The drug label says doses may be spaced further apart as care goes on, based on how well symptoms stay under control. A care team should base changes on your response, not just the date.
Which symptoms have changed most since the baseline visit?
Is the improvement steady, or does it fade between sessions?
Are remaining symptoms affecting safety or daily life?
Have new side effects, illnesses, or medicines appeared?
What would count as enough benefit to continue treatment?
If you do not feel better, say so, since it helps more to speak plainly than to guess what your provider wants to hear. Checks of Spravato treatment progress should cover both your results and what matters to you.
Treatment involves two kinds of checks: one looks at your mood and daily life over weeks. The other checks whether you can take a dose and go home safely. How you feel right after a dose does not prove that depression has improved.
According to MedlinePlus guidance on esketamine nasal spray, the medication may cause sedation (marked drowsiness), dizziness, dissociation (feeling detached from yourself or your surroundings), and breathing problems. You must stay in a care setting for at least two hours after a dose, and staff must check that it is safe for you to leave. You must not drive until the next day after a restful night’s sleep.
The team also checks blood pressure and other signs of safety. Tell the team about any side effect that worries you, even if your mood is better. Tell your care team right away about new or worse thoughts of suicide. If you may act on these thoughts, seek emergency care at once.
For people reviewing local options, the treatment-resistant depression page for Mesa explains local access to supervised care. Regardless of where you receive treatment, safety checks and symptom assessments serve different purposes, and both matter.
Yes. Some people notice better sleep, concentration, or motivation before they feel a major change in mood. Your provider can compare these signs with your baseline and overall symptom pattern. Partial improvement is worth discussing, but it does not mean remaining symptoms should be ignored.
Providers may ask about mood and recent changes during visits, while more detailed rating scales or reviews may occur at planned intervals. The exact routine varies. Each administration also requires safety monitoring, which is different from assessing longer-term antidepressant effects.
Tell your provider. Scores summarize symptoms but cannot capture every part of daily life. Your care team can look at each answer, ask about daily tasks, and see if the score fits your life. A score should support a conversation, not end it.
No. Dizziness and dissociation are possible medication effects, not reliable proof of depression relief. Clinicians assess benefit through changes in symptoms and functioning over time. Report uncomfortable effects so they can also evaluate treatment safety.
Mood can vary for many reasons, including stress, sleep changes, or depression itself. Record when the change happened and how long it lasted. Tell your clinician about worsening symptoms rather than waiting for the next major review, especially if your safety is affected.
Discuss any change with your prescriber first. Improvement is one part of the decision, but the risk of symptoms returning and your overall health matter too. Your clinician can explain the options and how symptoms would be monitored if the plan changes.
Short notes can make check-ins less stressful, even without a complex chart or daily journal. A few notes each week may tell you more than trying to recall the past month.
For each week, consider noting:
One symptom that improved, stayed the same, or worsened.
A real example of what you could or could not do.
Changes in sleep, energy, or appetite.
Any new medication, health issue, or major life event.
Questions you want to ask at your next appointment.
You might write, “I went grocery shopping twice this week, but I still struggled to get out of bed on Saturday.” That tells your provider more than a simple “fine” or “bad.” It also keeps your expectations grounded in everyday experiences.
Tracking Spravato treatment progress is not a test of how hard you try. It helps you and your care team decide what has changed and what still needs care.
Changes over time: Care teams track depression symptoms and your ability to manage daily tasks.
A starting point: A baseline shows what has changed since care began.
Rating scales: Scores show trends, while your own experience adds context.
Response and remission: Response means clear improvement; remission means few or no symptoms remain.
Four-week review: Your care team checks if Spravato has helped enough to keep going.
Safety checks: Checks after each dose differ from reviews of longer-term relief.
Personal notes: Brief notes about daily life can help at your next visit.
Disclaimer: This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Spravato must be administered under qualified healthcare supervision, and individual treatment decisions depend on a clinical evaluation. Do not start, stop, or change prescribed treatment without consulting your clinician. If you are in immediate danger or experiencing thoughts of self-harm, seek urgent emergency or crisis support.